Dr Agarwals Healthcare IPO opens on Jan 29, 2025, with a price band of ₹382 to ₹402 per share. Minimum investment of ₹14,070. The allotment date is set as Feb 3, 2025.
Dr Agarwals Health Care Limited is set to launch its IPO on January 29, 2025. It is one of the anticipated upcoming IPOs in India. Here are the key details to note about the Dr Agarwals Healthcare IPO.
Key Details of Dr Agarwals Healthcare IPO to Note
- Open and Close Dates: Dr Agarwals Healthcare IPO will open for subscription on January 29, 2025, and will close on January 31, 2025.
- Allotment Date: The allotment for the IPO is anticipated to be on or before Monday, February 3, 2025.
- Listing Date: The shares will be listed on the BSE and NSE, with a tentative listing date set for Wednesday, February 5, 2025.
- Price Band: The price band for the Dr Agarwals Healthcare IPO is set between ₹382 to ₹402 per share, with a minimum application lot size of 35 shares. Retail investors need to make a minimum investment of ₹14,070.
- Offer Size: The IPO will be a book-built issue amounting to ₹3,027.26 crore, which includes a fresh issue of 0.75 crore shares of ₹300.00 crore and an offer for sale of 6.78 crore shares of ₹2,727.26 crore.
- Objects of the Issue: As per the RHP, the proceeds from the fresh issue will be used for the repayment/prepayment, in full or in part, of certain borrowings made by the company and for general corporate purposes.
| Particulars |
As at and for the six months ended September 30, 2024 |
As at and for the six months ended September 30, 2023 |
As at and for the FY ended March 31, 2024 |
As at and for the FY ended March 31, 2023 |
As at and for the FY ended March 31, 2022 |
| Net Worth (₹ in million) |
15,026.67 |
12,869.33 |
13,376.84 |
6,278.33 |
2,123.37 |
| Total Income (₹ in million) |
8,379.40 |
6,626.90 |
13,764.49 |
10,314.94 |
7,137.84 |
| Revenue from Operations (₹ in million) |
8,200.63 |
6,505.75 |
13,321.52 |
10,179.80 |
6,960.78 |
| Restated Profit for the period/year (₹ in million) |
395.64 |
311.33 |
950.51 |
1,032.30 |
431.64 |
| Total Borrowings (₹ in million) |
3,736.82 |
3,946.90 |
3,877.87 |
3,561.77 |
2,901.80 |
Strengths and Risks
Strengths:
- As per the RHP, Dr Agarwals Health Care Limited is India’s largest eye care service chain by revenue for FY 2024, generating ~1.7 times the revenue of the second-largest eye care chain in the country during the same period.
- The company offers comprehensive, end-to-end eye care services, enabling it to address all ophthalmic needs of its patients.
- Dr Agarwals operates on a “hub-and-spoke” model, which facilitates high patient volumes, enhances resource efficiency, and provides greater accessibility and choice to patients.
Risks:
- The company engages doctors through retainership arrangements, which may be prematurely terminated. Any inability to attract and retain medical professionals could adversely impact its business, financial condition, and operations.
- Operating in a regulated industry, failure to comply with safety, health, environmental, labor, or other regulations, or issues in obtaining or renewing approvals, could harm the company’s reputation, business, and financial performance.
- A significant majority of the company’s facilities are concentrated in Tamil Nadu (primarily Chennai), Maharashtra, and Karnataka. Adverse developments affecting these regions could negatively impact its operations and financial outcomes.
About Dr Agarwals Health Care Limited
Dr Agarwals provides a wide range of eye care services, including cataract, refractive, and other surgeries. The company also offers consultations, diagnoses, non-surgical treatments, optical products, contact lenses, accessories, and eye care-related pharmaceutical products.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
